The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment.
作者信息
Grani Giorgio, Ciotti Laura, Del Gatto Valeria, Montesano Teresa, Biffoni Marco, Giacomelli Laura, Sponziello Marialuisa, Pecce Valeria, Lucia Piernatale, Verrienti Antonella, Filetti Sebastiano, Durante Cosimo
机构信息
Department of Translational and Precision Medicine, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
Department of Surgical Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
出版信息
Endocrine. 2022 Nov;78(2):387-391. doi: 10.1007/s12020-022-03131-7. Epub 2022 Jul 8.
Abstract
摘要
相似文献
1
The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment.新冠疫情与甲状腺癌诊疗的降级
Endocrine. 2022 Nov;78(2):387-391. doi: 10.1007/s12020-022-03131-7. Epub 2022 Jul 8.
2
Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil.COVID-19 大流行对巴西甲状腺癌诊断和治疗的影响。
Front Endocrinol (Lausanne). 2022 Oct 5;13:995329. doi: 10.3389/fendo.2022.995329. eCollection 2022.
3
Recent advances in thyroid cancer.甲状腺癌的最新进展
Curr Probl Surg. 2008 Mar;45(3):156-250. doi: 10.1067/j.cpsurg.2007.12.010.
4
Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.分化型甲状腺癌：ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2008 May;19 Suppl 2:ii99-101. doi: 10.1093/annonc/mdn115.
5
Thyroid cancer: diagnosis and management.甲状腺癌：诊断与管理
Singapore Med J. 2007 Feb;48(2):107-12; quiz 113.
6
The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations.新冠疫情给甲状腺癌患者留下的影响：迈向临床实践建议的应用
Endocrine. 2023 Jan;79(1):45-48. doi: 10.1007/s12020-022-03132-6. Epub 2022 Jul 20.
7
Serratia marcescens outbreak in a COVID-19 intensive care unit - Are there any factors specific to COVID-19 units that facilitate bacterial cross-contamination between COVID-19 patients?耐瑟氏菌属在 COVID-19 重症监护病房的爆发——COVID-19 病房中是否存在任何特定于 COVID-19 的因素，使 COVID-19 患者之间的细菌交叉污染更容易发生？
Am J Infect Control. 2022 Feb;50(2):223-225. doi: 10.1016/j.ajic.2021.10.005. Epub 2021 Oct 21.
8
Thyroid cancer in the Era of COVID-19.COVID-19 时代的甲状腺癌。
Endocrine. 2020 Oct;70(1):1-5. doi: 10.1007/s12020-020-02439-6. Epub 2020 Aug 4.
9
Thyroid cancer in the age of COVID-19.新冠疫情时代的甲状腺癌。
Endocr Relat Cancer. 2020 Nov;27(11):R407-R416. doi: 10.1530/ERC-20-0279.
10
New developments in the diagnosis and treatment of thyroid cancer.甲状腺癌的诊断与治疗新进展。
CA Cancer J Clin. 2013 Nov-Dec;63(6):374-94. doi: 10.3322/caac.21195. Epub 2013 Jun 24.
引用本文的文献
1
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study.T1bN1期甲状腺乳头状癌患者延迟手术治疗对预后的短期影响：一项回顾性队列研究
BMC Cancer. 2025 May 27;25(1):950. doi: 10.1186/s12885-025-14371-x.
2
Comparison of Clinical and Pathological Characteristics of Thyroid Cancer Surgery in the Pandemic Era.大流行时代甲状腺癌手术的临床和病理特征比较
Med J Islam Repub Iran. 2024 Aug 28;38:99. doi: 10.47176/mjiri.38.99. eCollection 2024.
3
The effect of COVID-19 pandemic restrictions on the management of differentiated thyroid cancer in Turkey: a single tertiary centre experience.COVID-19 大流行限制措施对土耳其分化型甲状腺癌管理的影响：单中心经验。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2587-2595. doi: 10.1007/s00405-024-08496-1. Epub 2024 Feb 13.
4
Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.COVID-19 大流行对甲状腺不确定结节（THYCOVID）手术的影响：一项回顾性、国际性、多中心、横断面研究。
Lancet Diabetes Endocrinol. 2023 Jun;11(6):402-413. doi: 10.1016/S2213-8587(23)00094-3. Epub 2023 Apr 28.
5
A Global Review of the Impacts of the Coronavirus (COVID-19) Pandemic on Radiology Practice, Finances, and Operations.冠状病毒（COVID-19）大流行对放射学实践、财务和运营影响的全球综述。
Life (Basel). 2023 Apr 6;13(4):962. doi: 10.3390/life13040962.
6
Surgical Protocols before and after COVID-19-A Narrative Review.2019冠状病毒病前后的手术方案：一篇叙述性综述
Vaccines (Basel). 2023 Feb 14;11(2):439. doi: 10.3390/vaccines11020439.
7
Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil.COVID-19 大流行对巴西甲状腺癌诊断和治疗的影响。
Front Endocrinol (Lausanne). 2022 Oct 5;13:995329. doi: 10.3389/fendo.2022.995329. eCollection 2022.
本文引用的文献
1
More Aggressive Cancer Behaviour in Thyroid Cancer Patients in the Post-COVID-19 Pandemic Era: A Retrospective Study.新冠疫情后时代甲状腺癌患者更具侵袭性的癌症行为：一项回顾性研究
Int J Gen Med. 2021 Oct 27;14:7197-7206. doi: 10.2147/IJGM.S339998. eCollection 2021.
2
What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer.2019冠状病毒病时期的择期肿瘤手术是什么？关于手术延迟对癌症患者预后影响的文献综述
Clin Oncol Res. 2020 Jun;3(6):1-11. doi: 10.31487/j.COR.2020.06.05. Epub 2020 Jun 26.
3
The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study.THYCOVIT（意大利 COVID-19 大流行期间的甲状腺手术）研究：一项全国性、多中心、病例对照研究的结果。
Updates Surg. 2021 Aug;73(4):1467-1475. doi: 10.1007/s13304-021-01051-1. Epub 2021 Apr 16.
4
Cytopathology practice during the COVID-19 postlockdown: An Italian experience.新冠疫情封锁后的细胞病理学实践：意大利经验。
Cancer Cytopathol. 2021 Jul;129(7):548-554. doi: 10.1002/cncy.22416. Epub 2021 Feb 17.
5
Selective Use of Radioactive Iodine Therapy for Papillary Thyroid Cancers With Low or Lower-Intermediate Recurrence Risk.低危或中危复发风险的甲状腺乳头状癌的放射性碘治疗的选择性应用。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):e1717-e1727. doi: 10.1210/clinem/dgaa973.
6
Delays to Low-risk Thyroid Cancer Treatment During COVID-19-Refocusing From What Has Been Lost to What May Be Learned and Gained.COVID-19 期间低风险甲状腺癌治疗的延迟——从已失去的转向可能学到和获得的。
JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):5-6. doi: 10.1001/jamaoto.2020.3878.
7
Cancer Care During COVID-19 Era: The Quality of Life of Patients With Thyroid Malignancies.新冠疫情时代的癌症护理：甲状腺恶性肿瘤患者的生活质量
Front Oncol. 2020 Jun 23;10:1128. doi: 10.3389/fonc.2020.01128. eCollection 2020.
8
Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?在 COVID-19 大流行期间进行的内分泌外科手术：意大利是否需要更新手术适应证？
Endocrine. 2020 Jun;68(3):485-488. doi: 10.1007/s12020-020-02357-7. Epub 2020 Jun 4.
9
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.2019冠状病毒病与内分泌疾病。欧洲内分泌学会声明。
Endocrine. 2020 Apr;68(1):2-5. doi: 10.1007/s12020-020-02294-5.
10
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules.双组分分子检测在细胞学检查结果不确定的甲状腺结节中的性能
Endocrine. 2020 May;68(2):458-465. doi: 10.1007/s12020-020-02271-y. Epub 2020 Mar 30.
Zotero 插件